DE60311456D1 - Verfahren zur herstellung von eisenhydroxypyronverbindungen - Google Patents
Verfahren zur herstellung von eisenhydroxypyronverbindungenInfo
- Publication number
- DE60311456D1 DE60311456D1 DE60311456T DE60311456T DE60311456D1 DE 60311456 D1 DE60311456 D1 DE 60311456D1 DE 60311456 T DE60311456 T DE 60311456T DE 60311456 T DE60311456 T DE 60311456T DE 60311456 D1 DE60311456 D1 DE 60311456D1
- Authority
- DE
- Germany
- Prior art keywords
- producing iron
- iron hydroxypyrone
- hydroxypyrone compounds
- compounds
- hydroxypyrone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/34—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D309/36—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
- C07D309/40—Oxygen atoms attached in positions 3 and 4, e.g. maltol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compounds Of Iron (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0211500.4A GB0211500D0 (en) | 2002-05-18 | 2002-05-18 | Method of forming iron hydroxypyrone compounds |
GB0211500 | 2002-05-18 | ||
PCT/GB2003/001956 WO2003097627A1 (en) | 2002-05-18 | 2003-05-07 | Method of forming iron hydroxypyrone compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60311456D1 true DE60311456D1 (de) | 2007-03-15 |
DE60311456T2 DE60311456T2 (de) | 2007-11-15 |
Family
ID=9936987
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60311456T Expired - Lifetime DE60311456T2 (de) | 2002-05-18 | 2003-05-07 | Verfahren zur herstellung von eisenhydroxypyronverbindungen |
Country Status (11)
Country | Link |
---|---|
US (1) | US7459569B2 (de) |
EP (1) | EP1506183B1 (de) |
AT (1) | ATE352547T1 (de) |
AU (1) | AU2003233881A1 (de) |
BE (1) | BE2016C041I2 (de) |
CA (1) | CA2483067C (de) |
DE (1) | DE60311456T2 (de) |
ES (1) | ES2283771T3 (de) |
FR (1) | FR16C0033I2 (de) |
GB (1) | GB0211500D0 (de) |
WO (1) | WO2003097627A1 (de) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8952061B2 (en) * | 2006-08-22 | 2015-02-10 | University Of Virginia Patent Foundation | Methods and compounds regulating the erythroid response to iron deficiency |
PL2125847T3 (pl) | 2007-02-06 | 2015-12-31 | Medical Res Council | Materiały poli okso-hydroksy jonów metalu zmodyfikowanych ligandem, ich zastosowania i sposoby ich otrzymywania |
GB0808835D0 (en) | 2008-05-15 | 2008-06-18 | Vitra Pharmaceuticals Ltd | Therapeutic compositions |
US8536106B2 (en) | 2010-04-14 | 2013-09-17 | Ecolab Usa Inc. | Ferric hydroxycarboxylate as a builder |
GB201101370D0 (en) * | 2011-01-27 | 2011-03-09 | Iron Therapeutics Holdings Ag | Process |
GB201404390D0 (en) * | 2014-03-12 | 2014-04-23 | Iron Therapeutics Holdings Ag | Composition |
US10172882B2 (en) | 2014-06-22 | 2019-01-08 | Dexcel Pharma Technologies Ltd. | Pharmaceutical compositions comprising ferric citrate and methods for the production thereof |
GB2531742B (en) * | 2014-10-28 | 2016-10-05 | Iron Therapeutics Holdings Ag | Polymorphs of ferric maltol |
GB201517893D0 (en) | 2015-10-09 | 2015-11-25 | Medical Res Council | Methods for producing carboxylate ligand modified ferric iron hydroxide colloids |
CA3019478C (en) | 2016-03-31 | 2024-02-13 | United Kingdom Research And Innovation | Ferric maltol compositions for use in the treatment or prevention of cancer and tumours |
AU2017242906B2 (en) * | 2016-03-31 | 2020-11-19 | Shield TX (UK) Limited | Methods for producing Ferric maltol compositions from Ferrous Hydroxides |
AU2017242905B2 (en) * | 2016-03-31 | 2020-10-22 | Shield TX (UK) Limited | Methods for producing ferric maltol compositions from elemental iron |
WO2017167963A1 (en) * | 2016-03-31 | 2017-10-05 | Medical Research Council | Methods for producing ferric maltol compositions from ligand modified and ligand coated ferric hydroxides |
GB202005054D0 (en) | 2020-04-06 | 2020-05-20 | Nemysis Ltd | Carboxylate Ligand Modified Ferric Iron Hydroxide Compositions for Use in the Treatment or Prevention of Iron Deficiency Associated with Liver Diseases |
CN112574158B (zh) * | 2020-12-29 | 2022-08-02 | 南京百泽医药科技有限公司 | 一种麦芽酚铁晶型ii及其制备方法 |
CN115177625A (zh) * | 2022-06-28 | 2022-10-14 | 金陵药业股份有限公司 | 一种羧基麦芽糖铁药用组合物及其制备方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3130204A (en) * | 1962-02-07 | 1964-04-21 | Pfizer & Co C | Preparation of gamma-pyrones |
DE1518098A1 (de) * | 1963-09-19 | 1969-04-10 | Pfizer & Co C | Verfahren zur Herstellung von Pyromekonsaeurederivaten |
SE322866B (de) * | 1966-12-15 | 1970-04-20 | Astra Ab | |
US4018907A (en) * | 1975-08-25 | 1977-04-19 | General Foods Corporation | Coloring food with iron-complexes |
US4212685A (en) * | 1978-12-11 | 1980-07-15 | Lea Manufacturing Company | Protective and color receptive coating for aluminum |
US4279936A (en) * | 1979-09-24 | 1981-07-21 | William Underwood Company | Maltol treated canned meat process |
EP0094149B1 (de) * | 1982-03-24 | 1986-09-10 | National Research Development Corporation | Pharmazeutische Zusammensetzungen, die Eisen-Komplexe von N-substituierten 3-Hydroxypyrid-2-on- oder -4-on-Derivaten enthalten |
GR78491B (de) | 1982-03-24 | 1984-09-27 | Nat Res Dev | |
EP0107458B1 (de) * | 1982-10-22 | 1987-07-29 | National Research Development Corporation | Pharmazeutische Zusammensetzungen |
GB8308055D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8308054D0 (en) * | 1983-03-24 | 1983-05-05 | Hider R C | Pharmaceutical compositions |
GB8325496D0 (en) * | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
US4912118A (en) | 1983-09-23 | 1990-03-27 | National Research Development Corporation | Pharmaceutical compositions |
GB8325494D0 (en) | 1983-09-23 | 1983-10-26 | Hider R C | Pharmaceutical compositions |
USRE34313E (en) | 1983-09-23 | 1993-07-13 | National Research Development Corporation | Pharmaceutical compositions |
GB8329043D0 (en) * | 1983-10-31 | 1983-11-30 | Hider R C | Pharmaceutical compositions |
GB8410290D0 (en) * | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
GB8410289D0 (en) | 1984-04-19 | 1984-05-31 | Callingham B A | Pharmaceutical compositions |
US5177068A (en) | 1984-04-19 | 1993-01-05 | National Research Development Corporation | Pharmaceutical compositions |
GB8606913D0 (en) | 1986-03-20 | 1986-04-23 | Hider R C | Treatment of sickle cell disease |
JPH0367565A (ja) | 1989-08-07 | 1991-03-22 | Kansai Paint Co Ltd | 鉄分強化食品 |
GB9209078D0 (en) | 1992-04-27 | 1992-06-10 | Hider Robert C | Pharmaceutical compositions |
GB9217099D0 (en) | 1992-08-12 | 1992-09-23 | British Tech Group | Pharmaceutical compositions |
EP0833627B1 (de) * | 1995-06-10 | 2004-08-18 | Vitra Pharmaceuticals Ltd. | Eisenverbindungen, zusammensetzungen, herstellungsverfahren und verwendungen davon |
GB9621273D0 (en) | 1996-10-11 | 1996-11-27 | Cortecs Ltd | Therapeutic method |
-
2002
- 2002-05-18 GB GBGB0211500.4A patent/GB0211500D0/en not_active Ceased
-
2003
- 2003-05-07 EP EP03727643A patent/EP1506183B1/de not_active Expired - Lifetime
- 2003-05-07 CA CA2483067A patent/CA2483067C/en not_active Expired - Lifetime
- 2003-05-07 US US10/514,836 patent/US7459569B2/en not_active Expired - Lifetime
- 2003-05-07 WO PCT/GB2003/001956 patent/WO2003097627A1/en active Search and Examination
- 2003-05-07 ES ES03727643T patent/ES2283771T3/es not_active Expired - Lifetime
- 2003-05-07 DE DE60311456T patent/DE60311456T2/de not_active Expired - Lifetime
- 2003-05-07 AT AT03727643T patent/ATE352547T1/de not_active IP Right Cessation
- 2003-05-07 AU AU2003233881A patent/AU2003233881A1/en not_active Abandoned
-
2016
- 2016-08-09 FR FR16C0033C patent/FR16C0033I2/fr active Active
- 2016-08-17 BE BE2016C041C patent/BE2016C041I2/nl unknown
Also Published As
Publication number | Publication date |
---|---|
ES2283771T3 (es) | 2007-11-01 |
EP1506183A1 (de) | 2005-02-16 |
CA2483067C (en) | 2011-04-26 |
US7459569B2 (en) | 2008-12-02 |
FR16C0033I2 (fr) | 2018-01-19 |
BE2016C041I2 (de) | 2022-08-09 |
FR16C0033I1 (de) | 2016-09-23 |
WO2003097627A1 (en) | 2003-11-27 |
ATE352547T1 (de) | 2007-02-15 |
CA2483067A1 (en) | 2003-11-27 |
EP1506183B1 (de) | 2007-01-24 |
AU2003233881A1 (en) | 2003-12-02 |
DE60311456T2 (de) | 2007-11-15 |
GB0211500D0 (en) | 2002-06-26 |
US20050250754A1 (en) | 2005-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BE2016C041I2 (de) | ||
ATE261946T1 (de) | Verfahren zur herstellung von thiazolidin | |
ATE466830T1 (de) | Verfahren zur herstellung von carbonsäuresalzen | |
ATE316959T1 (de) | Verfahren zur herstellung von 2- halogenpyridincarbonsäureamiden | |
ATE332189T1 (de) | Verfahren zur herstellung von carbonsäuresalzen | |
ATE327219T1 (de) | Verfahren zur herstellung von hydroxymethylthiobuttersäure | |
ATE370940T1 (de) | Verfahren zur herstellung von (s)- glyceraldehydacetonid | |
ATE305919T1 (de) | Verfahren zur herstellung von salzen der methallylsulfonsäure | |
DE69918050D1 (de) | Verfahren zur herstellung von (2r, 3s)-amino-1,2-oxiran | |
DE50209165D1 (de) | Verfahren zur herstellung von d-pantothensäure und/oder salze als zusatz zu tierfuttermitteln | |
ATE301634T1 (de) | Verfahren zur herstellung von alpha- hydroxycarbonsäureamiden | |
ATE385232T1 (de) | Verfahren zur herstellung von 3, 3', 6, 6'- tetraalkylen-2, 2'-biphenolen und 3, 3', 6, 6'- tetraalkylen-5, 5'-dihalo-2, 2' biphenolen | |
ATE303356T1 (de) | Verfahren zur herstellung von alkylendiamintriessigsäure | |
DE50208413D1 (de) | Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln | |
DE50209076D1 (de) | Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln | |
WO2002066663A3 (de) | Verfahren zur herstellung von d-pantothensäure und/oder deren salze als zusatz zu tierfuttermitteln | |
ATE404559T1 (de) | Verfahren zur herstellung von säuresalzen von gemifloxacin | |
ATE330932T1 (de) | Verfahren zur herstellung von 3- aminoalkansäureestern | |
ATE517870T1 (de) | Verfahren zur herstellung von alpha- aminosubstituierten carbonsäureamiden | |
ATE247084T1 (de) | Verfahren zur herstellung von hydroxamsäuren | |
ATE361292T1 (de) | Verfahren zur herstellung von fumagillin | |
ATE361275T1 (de) | Verfahren zur herstellung von n-substituierten hydroxylaminen und deren salzen | |
ATE221727T1 (de) | Verfahren zur reduzierung von die aminosäurenbiosynthese inhibierenden effekten einer auf sulphonylharnstoff basierenden verbindung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R065 | Request for grant of supplementary protection certificate validly filed |
Free format text: PRODUCT NAME: EISEN(III)-MALTOL; REGISTRATION NO/DATE: EU/1/15/1075/001 20160218 Spc suppl protection certif: 122016000055 Filing date: 20160727 Expiry date: 20230508 Extension date: 20280507 |
|
R067 | Examining division decision granting supplementary protection certificate |
Free format text: PRODUCT NAME: EISEN(III)-MALTOL; REGISTRATION NO/DATE: EU/1/15/1075/001 20160218 Spc suppl protection certif: 122016000055 Filing date: 20160727 Expiry date: 20230508 Extension date: 20280507 |
|
R069 | Supplementary protection certificate granted |
Free format text: PRODUCT NAME: EISEN(III)-MALTOL; REGISTRATION NO/DATE: EU/1/15/1075/001 20160218 Spc suppl protection certif: 122016000055 Filing date: 20160727 Expiry date: 20230508 Extension date: 20280507 |